INDV · Indivior Pharmaceuticals, Inc. Common Stock

INDV Indivior Pharmaceuticals, Inc. Common Stock

Healthcare & Biotech · Healthcare · ← Healthcare & Biotech Index

Gesamt +70%RS-Rating 85vom Hoch -8%Ø $-Vol 67MMax-Runup +459%Max-DD -71%ADR 3.4%Score 57Setups 2Rallyes 3Earnings 5Surf 100%🏄 10/20-Surfer

▲ im Chart anklicken → springt zur Zeile

Grade	Base-Start	Breakout	Tage	Tiefe%	Vorlauf%	Δ Tag%	Gap%	Vol×	Dry-Up%	ADR%	ext10%	Surf%	Setup	Formation	Katalysator
C	2024-01-24	2024-02-22	20	10.3	+27	+21.7	14.6	4.2	-161	3.0	18	95	Episodic Pivot (Gap)	Flat Base	—:
C	2025-10-16	2025-10-30	10	6.9	+58	+15.4	18.9	7.4	51	3.5	15	100	Episodic Pivot (Gap)	Flag / Pennant	Earnings: Earnings-Report (SEC 8-K 2.02)

Breakouts 2Trefferquote 100%Ø gehalten +25.8%Median +39.3%Ø Peak +38%Ø hergegeben −12%

Breakout	G	Entry	gehalten	Peak	hergeg.	Tage	Exit
2024-02-22	C	18.33	+12.4%	+26.7%	−14.3%	17	2024-03-18
2025-10-30	C	25.49	+39.3%	+49.1%	−9.8%	47	2026-01-08

Regel: Einstieg am Breakout-Pivot, Trailing-Stop = Tagesschluss unter dem 20-EMA. gehalten = realisierter Gewinn bis zum Stop · Peak = max. Run-Up (MFE) · hergeg. = Peak − gehalten · „offen" = Position läuft noch.

Jahr	Rendite	Spanne	Max-DD	Setups	Schluss
2023	-31%	73%	-41%		15.27
2024	-19%	217%	-68%	1	12.43
2025	+189%	399%	-34%	1	35.88
2026	+5%	48%	-21%		37.62

▲ 2025-02-24 → 2026-05-06 +393% (301 HT)

Auslöser: Earnings: Earnings-Report (SEC 8-K 2.02)

2025-07-31 +16% [Earnings] Earnings-Report (SEC 8-K 2.02)
2025-10-30 +15% [Earnings] Earnings-Report (SEC 8-K 2.02)

▲ 2024-10-11 → 2025-01-02 +68% (56 HT)

Auslöser: — (Momentum/sektorgetrieben)

▲ 2023-12-18 → 2024-03-01 +58% (50 HT)

Auslöser: — (Momentum/sektorgetrieben)